Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Results are consistent with what the STEP and SURMOUNT trials showed under supervised conditions
If you are considering changes to your treatment plan, the best step is to consult your healthcare provider
NICE guidance (NG28) recommends considering GLP-1 receptor agonists for adults with type 2 diabetes when glycaemic targets are not achieved with other therapies, particularly in those with established cardiovascular disease or at high cardiovascular risk
Polvo: Mezclado con bebidas
Its effects are linked to a group of hormones known as GLP-1, which play a crucial role in controlling hunger and glucose metabolism
Note: Wegovy s discounted program is not available for people who use Medicare, Medicaid, or other government-funded insurance plans
